扫码关注公众号           扫码咨询技术支持           扫码咨询技术服务
  
客服热线:400-901-9800  客服QQ:4009019800  技术答疑  技术支持  质量反馈  人才招聘  关于我们  联系我们
产品中心-北京博奥森生物技术有限公司
Recombinant human SREBP1 protein, N-His (bs-42634P)  
订购热线:400-901-9800
订购邮箱:sales@bioss.com.cn
订购QQ:  400-901-9800
技术支持:techsupport@bioss.com.cn
20ug/580.00元
100ug/1880.00元
500ug/5680.00元
大包装/询价
产品编号 bs-42634P
英文名称 Recombinant human SREBP1 protein, N-His
中文名称 重组人胆固醇调节元件结合蛋白1蛋白
别    名 HMD; IFAP2; SREBP1; bHLHd1; ADD1; ADD-1; SREBP-1; SREBP-1c; SRBP1_HUMAN; SREBF1; Class D basic helix-loop-helix protein 1 (bHLHd1); Sterol regulatory element-binding transcription factor 1;  
理论分子量 37.1kDa
性    状 Liquid
浓    度 >1mg/ml
纯    度 >90% as determined by SDS-PAGE
缓 冲 液 20mM Tris-Hcl (pH=8.0) with 1500mM NaCL
保存条件 Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles.
注意事项 This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
产品介绍 This gene encodes a transcription factor that binds to the sterol regulatory element-1 (SRE1), which is a decamer flanking the low density lipoprotein receptor gene and some genes involved in sterol biosynthesis. The protein is synthesized as a precursor that is attached to the nuclear membrane and endoplasmic reticulum. Following cleavage, the mature protein translocates to the nucleus and activates transcription by binding to the SRE1. Sterols inhibit the cleavage of the precursor, and the mature nuclear form is rapidly catabolized, thereby reducing transcription. The protein is a member of the basic helix-loop-helix-leucine zipper (bHLH-Zip) transcription factor family. This gene is located within the Smith-Magenis syndrome region on chromosome 17. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

SWISS:
P36956

Gene ID:
6720

转录调节因子(Transcriptin Regulators) 胆固醇调节元件结合蛋白1(SREBP1)是膜结合的转录因子,参与脂质自稳态的许多作用(胆固醇、脂肪酸、甘油三酯和磷酯的合成/摄取).SREBP1在内质网上合成,需要被转运到高尔基体并经过一系列蛋白水解后才能到核内发挥作用。 未成熟时在胞浆表达,水解后的成熟片段在胞核表达。
版权所有 2004-2026 www.bioss.com.cn 北京博奥森生物技术有限公司
通过国际质量管理体系ISO 9001:2015 GB/T 19001-2016    证书编号: 00124Q34771R2M/1100
通过国际医疗器械-质量管理体系ISO 13485:2016 GB/T 42061-2022     证书编号: CQC24QY20047R0M/1100
京ICP备05066980号-1         京公网安备110107000727号